Atlas Trials

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Clinical trial NCT06747351 · RECRUITING

Trial details

NCT number
NCT06747351
Sponsor
Takeda
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Start date
2025-05-06
Primary completion
2028-06-25
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.